Winston Medical Supply Co., Ltd. (TPEX:6817)
Taiwan · Delayed Price · Currency is TWD 63.60
+0.90 (1.44%)
May 29, 2026, 1:41 PM CST
Winston Medical Supply Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 700.07 | 695.08 | 709.07 | 606.52 | 536.53 | |
Revenue Growth (YoY) | 0.72% | -1.97% | 16.91% | 13.05% | 6.22% |
Cost of Revenue | 396.31 | 379.24 | 361.48 | 342.07 | 299.13 |
Gross Profit | 303.77 | 315.84 | 347.6 | 264.45 | 237.39 |
Selling, General & Admin | 153.19 | 147.16 | 142.87 | 122.89 | 113.21 |
Research & Development | 8.76 | 9.43 | 8.64 | 7 | 7.72 |
Operating Expenses | 161.95 | 156.59 | 151.5 | 128.59 | 122.11 |
Operating Income | 141.82 | 159.26 | 196.1 | 135.86 | 115.29 |
Interest Expense | -1.19 | -1.17 | -1.53 | -1.06 | -1.84 |
Interest & Investment Income | 2.87 | 2.85 | 2.01 | 0.4 | 0.17 |
Currency Exchange Gain (Loss) | -0.09 | 0.39 | -0.19 | 0.08 | -0.2 |
Other Non Operating Income (Expenses) | 3.2 | 3.96 | 3.46 | 6.11 | 3.42 |
EBT Excluding Unusual Items | 146.6 | 165.29 | 199.85 | 141.4 | 116.84 |
Gain (Loss) on Sale of Assets | -0.47 | -1.11 | -1.03 | - | -0.25 |
Pretax Income | 146.13 | 164.18 | 198.82 | 141.4 | 116.59 |
Income Tax Expense | 28.84 | 32.59 | 40.06 | 30.14 | 24.46 |
Earnings From Continuing Operations | 117.29 | 131.59 | 158.76 | 111.26 | 92.13 |
Net Income to Company | 117.29 | 131.59 | 158.76 | 111.26 | 92.13 |
Net Income | 117.29 | 131.59 | 158.76 | 111.26 | 92.13 |
Net Income to Common | 117.29 | 131.59 | 158.76 | 111.26 | 92.13 |
Net Income Growth | -10.87% | -17.11% | 42.69% | 20.77% | -7.58% |
Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 |
Shares Change (YoY) | -0.05% | -0.04% | - | 0.27% | 3.93% |
EPS (Basic) | 6.37 | 7.15 | 8.62 | 6.04 | 5.04 |
EPS (Diluted) | 6.35 | 7.12 | 8.58 | 6.01 | 4.99 |
EPS Growth | -10.81% | -17.02% | 42.76% | 20.44% | -11.21% |
Free Cash Flow | 138.49 | 130.24 | 196.41 | 118.49 | 141.4 |
Free Cash Flow Per Share | 7.49 | 7.04 | 10.62 | 6.41 | 7.67 |
Dividend Per Share | 5.000 | 7.000 | 6.600 | 5.000 | 4.000 |
Dividend Growth | -28.57% | 6.06% | 32.00% | 25.00% | 33.33% |
Gross Margin | 43.39% | 45.44% | 49.02% | 43.60% | 44.25% |
Operating Margin | 20.26% | 22.91% | 27.66% | 22.40% | 21.49% |
Profit Margin | 16.75% | 18.93% | 22.39% | 18.34% | 17.17% |
Free Cash Flow Margin | 19.78% | 18.74% | 27.70% | 19.54% | 26.36% |
EBITDA | 164.57 | 185.07 | 221.25 | 171.37 | 149.31 |
EBITDA Margin | 23.51% | 26.63% | 31.20% | 28.26% | 27.83% |
D&A For EBITDA | 22.75 | 25.82 | 25.15 | 35.51 | 34.03 |
EBIT | 141.82 | 159.26 | 196.1 | 135.86 | 115.29 |
EBIT Margin | 20.26% | 22.91% | 27.66% | 22.40% | 21.49% |
Effective Tax Rate | 19.73% | 19.85% | 20.15% | 21.31% | 20.98% |